Kalaris Therapeutics (KLRS) Restructuring Costs (2024 - 2026)
Kalaris Therapeutics (KLRS) posted quarterly Restructuring Costs of $2.7 million for Q1 2026, down 26.05% year-over-year from $3.6 million in Q1 2025, and up 28.12% quarter-over-quarter from $2.1 million in Q4 2025.
Kalaris Therapeutics (KLRS) Restructuring Costs (2024 - 2026) Analysis & Trends
Kalaris Therapeutics' Restructuring Costs history runs 3 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Restructuring Costs fell 26.05% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $10.0 million (up 24.96% YoY), while the FY2025 annual figure was $11.0 million, up 130.57% from the prior year.
- Restructuring Costs for Q1 2026 stood at $2.7 million, up from $2.1 million in the prior quarter.
- The five-year high for Restructuring Costs was $3.6 million in Q1 2025, with the low at $393000.0 in Q1 2024.
- The 3-year median for Restructuring Costs is $2.5 million (2025), against an average of $2.0 million.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs soared 827.99% in 2025, then slipped 26.05% in 2026.
- Kalaris Therapeutics' Restructuring Costs stood at $2.7 million in 2024, then dropped by 21.78% to $2.1 million in 2025, then gained by 28.12% to $2.7 million in 2026.
- Business Quant data shows KLRS's Restructuring Costs at $2.7 million in Q1 2026, $2.1 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Kalaris Therapeutics | 99.00 Mn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.15 Mn |
| Mar 31, 2026 | 2.70 Mn |
| Dec 31, 2025 | 2.11 Mn |
| Sep 30, 2025 | 2.48 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 3.65 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 417,000.00 |
| Mar 31, 2024 | 393,000.00 |